Skip to content
Thursday, February 9, 2023
Latest:
  • Men 60 and older with certain risk factors should get screened for life-threatening heart condition
  • Entanglement within a (transcriptional) bubble explains finely tuned regulation of gene expression
  • Philosophy, an ancient practice with modern appeal? The role of “big” questions in medical decision-making
  • Sensitive, rapid tests help to ID estrogen-disrupting chemicals in the environment
  • Why women with heart issues are undertreated and have worse outcomes than men

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

ALL

From The Labs 

Understanding the cancer risk in children with birth defects

June 25, 2020June 25, 2020ALL, Birth defects, cancer risk, hepatoblastoma, neuroblastoma, pediatric oncology, Research

Understanding the cancer risk in children with birth defects has been a challenge. Although scientific studies suggest that birth defects increase the risk of cancer,

Read more
From The Labs 

Trading a spear for a trident is promising in the fight against leukemia

April 14, 2020April 14, 2020ALL, CART cells, CD19, CD20, CD22, pediatric leukemia, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. While most children respond well to chemotherapy, some experience resistant or relapsed disease. Building on

Read more
Jeremy-Schraw-photo
From The Labs 

From my perspective: Dr. Jeremy Schraw shares his experiences during postdoctoral training

December 10, 2019December 10, 2019ALL, From my perspective, metabolomics, Pediatric Cancer, postdoc, Research

From the Labs interviewed Dr. Jeremy Schraw to learn about his experiences during his postdoctoral training at Baylor College of Medicine and Texas Children’s Hospital.

Read more
From The Labs 

Applying basic science helps predict poor treatment outcomes in ALL

November 21, 2019November 21, 2019Acute Lymphoblastic Leukemia, ALL, carbon metabolism, metabolome, Pediatric Cancer, prognosis, Research

The survival of patients with pediatric acute lymphoblastic leukemia (ALL) has significantly improved in the last several decades, but there is still a group of

Read more
From The Labs 

Exploring the risk of ALL in children with Down syndrome

September 24, 2019September 24, 2019Acute Lymphoblastic Leukemia, ALL, CDKN2A gene, Childhood leukemia, Down syndrome, IKZF1 gene, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: Adult-born neurons made the cover

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951